ArticleThe Journal of experimental medicine2024

Inhibition of hTERT/telomerase/telomere mediates therapeutic efficacy of osimertinib in EGFR mutant lung cancer.

Zhen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.